NO830732L - Fremgangsmaate for detektering eller bestemmelse av histamin i histaminholdige materialer, spesielt legemsvaesker og et analytisk middel for bruk i en slik fremgangsmaate - Google Patents

Fremgangsmaate for detektering eller bestemmelse av histamin i histaminholdige materialer, spesielt legemsvaesker og et analytisk middel for bruk i en slik fremgangsmaate

Info

Publication number: NO830732L
Authority: NO; Norway
Prior art keywords: histamine; labeled; glass; bound; amount
Prior art date: 1981-07-06

Application number

NO830732A

Other languages

English (en)

Norwegian (no)

Inventor

Per Stahl Skov

Svend Norn

Bent Weeke

Original Assignee

Per Stahl Skov

Svend Norn

Weeke Bengt

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-07-06

Filing date

1983-03-03

Publication date

1983-03-03

1983-03-03 Application filed by Per Stahl Skov, Svend Norn, Weeke Bengt filed Critical Per Stahl Skov

1983-03-03 Publication of NO830732L publication Critical patent/NO830732L/no

Links

NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims description 262
229960001340 histamine Drugs 0.000 claims description 129
238000000034 method Methods 0.000 claims description 60
239000011521 glass Substances 0.000 claims description 45
229920001410 Microfiber Polymers 0.000 claims description 39
239000003658 microfiber Substances 0.000 claims description 39
238000012360 testing method Methods 0.000 claims description 24
210000004369 blood Anatomy 0.000 claims description 21
239000008280 blood Substances 0.000 claims description 21
239000000835 fiber Substances 0.000 claims description 20
206010020751 Hypersensitivity Diseases 0.000 claims description 18
239000000463 material Substances 0.000 claims description 14
238000001514 detection method Methods 0.000 claims description 11
239000013566 allergen Substances 0.000 claims description 9
210000003743 erythrocyte Anatomy 0.000 claims description 7
210000002381 plasma Anatomy 0.000 claims description 7
208000030961 allergic reaction Diseases 0.000 claims description 6
210000001519 tissue Anatomy 0.000 claims description 6
230000002860 competitive effect Effects 0.000 claims description 4
210000001124 body fluid Anatomy 0.000 claims description 3
239000010839 body fluid Substances 0.000 claims description 3
102000004190 Enzymes Human genes 0.000 claims description 2
108090000790 Enzymes Proteins 0.000 claims description 2
239000010419 fine particle Substances 0.000 claims description 2
239000011888 foil Substances 0.000 claims description 2
239000003795 chemical substances by application Substances 0.000 claims 5
239000011230 binding agent Substances 0.000 claims 2
238000002405 diagnostic procedure Methods 0.000 claims 2
239000002245 particle Substances 0.000 claims 1
210000004027 cell Anatomy 0.000 description 16
238000004458 analytical method Methods 0.000 description 14
208000026935 allergic disease Diseases 0.000 description 10
230000007815 allergy Effects 0.000 description 10
229940046528 grass pollen Drugs 0.000 description 9
QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 8
238000001179 sorption measurement Methods 0.000 description 7
239000000126 substance Substances 0.000 description 7
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
210000003912 basophilic leucocyte Anatomy 0.000 description 6
239000003365 glass fiber Substances 0.000 description 6
108090000623 proteins and genes Proteins 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
230000000172 allergic effect Effects 0.000 description 5
208000010668 atopic eczema Diseases 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
102000004169 proteins and genes Human genes 0.000 description 5
238000005406 washing Methods 0.000 description 5
241000282326 Felis catus Species 0.000 description 4
238000010790 dilution Methods 0.000 description 4
239000012895 dilution Substances 0.000 description 4
230000002452 interceptive effect Effects 0.000 description 4
210000000265 leukocyte Anatomy 0.000 description 4
239000007788 liquid Substances 0.000 description 4
230000035945 sensitivity Effects 0.000 description 4
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
229960004784 allergens Drugs 0.000 description 3
239000006285 cell suspension Substances 0.000 description 3
238000005119 centrifugation Methods 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
230000008878 coupling Effects 0.000 description 3
238000010168 coupling process Methods 0.000 description 3
238000005859 coupling reaction Methods 0.000 description 3
229960002885 histidine Drugs 0.000 description 3
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
238000005259 measurement Methods 0.000 description 3
ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 3
239000004033 plastic Substances 0.000 description 3
229920003023 plastic Polymers 0.000 description 3
239000000843 powder Substances 0.000 description 3
238000004062 sedimentation Methods 0.000 description 3
229940076279 serotonin Drugs 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
206010001742 Allergy to animal Diseases 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
229920002307 Dextran Polymers 0.000 description 2
239000000427 antigen Substances 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
208000006673 asthma Diseases 0.000 description 2
230000008901 benefit Effects 0.000 description 2
238000012631 diagnostic technique Methods 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
229960004931 histamine dihydrochloride Drugs 0.000 description 2
210000003630 histaminocyte Anatomy 0.000 description 2
210000003405 ileum Anatomy 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
229940054441 o-phthalaldehyde Drugs 0.000 description 2
-1 polyethylene Polymers 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
239000000243 solution Substances 0.000 description 2
ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
239000000725 suspension Substances 0.000 description 2
210000002700 urine Anatomy 0.000 description 2
241000251468 Actinopterygii Species 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
201000004384 Alopecia Diseases 0.000 description 1
244000025254 Cannabis sativa Species 0.000 description 1
241000700198 Cavia Species 0.000 description 1
241000700199 Cavia porcellus Species 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
MURGITYSBWUQTI-UHFFFAOYSA-N Fluorescin Natural products OC(=O)C1=CC=CC=C1C1C2=CC=C(O)C=C2OC2=CC(O)=CC=C21 MURGITYSBWUQTI-UHFFFAOYSA-N 0.000 description 1
241000282412 Homo Species 0.000 description 1
102000008100 Human Serum Albumin Human genes 0.000 description 1
108091006905 Human Serum Albumin Proteins 0.000 description 1
240000004658 Medicago sativa Species 0.000 description 1
101710167853 N-methyltransferase Proteins 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
241000269821 Scombridae Species 0.000 description 1
208000024780 Urticaria Diseases 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
210000003651 basophil Anatomy 0.000 description 1
230000008033 biological extinction Effects 0.000 description 1
239000012620 biological material Substances 0.000 description 1
239000000969 carrier Substances 0.000 description 1
210000001175 cerebrospinal fluid Anatomy 0.000 description 1
239000005515 coenzyme Substances 0.000 description 1
230000008602 contraction Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
238000001035 drying Methods 0.000 description 1
239000000428 dust Substances 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
239000000284 extract Substances 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000011152 fibreglass Substances 0.000 description 1
235000019688 fish Nutrition 0.000 description 1
238000007421 fluorometric assay Methods 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
229940067406 glucose 1 mg/ml Drugs 0.000 description 1
208000024963 hair loss Diseases 0.000 description 1
230000003676 hair loss Effects 0.000 description 1
231100001261 hazardous Toxicity 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
238000011835 investigation Methods 0.000 description 1
238000002372 labelling Methods 0.000 description 1
238000011005 laboratory method Methods 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
235000020640 mackerel Nutrition 0.000 description 1
208000008585 mastocytosis Diseases 0.000 description 1
230000011987 methylation Effects 0.000 description 1
238000007069 methylation reaction Methods 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
230000020477 pH reduction Effects 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
235000011007 phosphoric acid Nutrition 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
238000002203 pretreatment Methods 0.000 description 1
230000005855 radiation Effects 0.000 description 1
239000012857 radioactive material Substances 0.000 description 1
230000009467 reduction Effects 0.000 description 1
239000001022 rhodamine dye Substances 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
229940063673 spermidine Drugs 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
238000010998 test method Methods 0.000 description 1
239000012085 test solution Substances 0.000 description 1
238000012549 training Methods 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
229910052722 tritium Inorganic materials 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/804—Radioisotope, e.g. radioimmunoassay
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/808—Automated or kit
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/81—Tube, bottle, or dipstick
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/145555—Hetero-N
- Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Cell Biology (AREA)
Medicinal Chemistry (AREA)
General Physics & Mathematics (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Pathology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Tropical Medicine & Parasitology (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physiology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Automatic Tool Replacement In Machine Tools (AREA)
Jigs For Machine Tools (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

NO830732A 1981-07-06 1983-03-03 Fremgangsmaate for detektering eller bestemmelse av histamin i histaminholdige materialer, spesielt legemsvaesker og et analytisk middel for bruk i en slik fremgangsmaate NO830732L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DK298281A DK157218C (da)	1981-07-06	1981-07-06	Fremgangsmaade til paavisning eller bestemmelse af histamin i legemsvaesker navnlig blod eller blodfraktioner, samt analyseanordning til anvendelse ved idoevelse af fremgangsmaaden

Publications (1)

Publication Number	Publication Date
NO830732L true NO830732L (no)	1983-03-03

Family

ID=8117827

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO830732A NO830732L (no)	1981-07-06	1983-03-03	Fremgangsmaate for detektering eller bestemmelse av histamin i histaminholdige materialer, spesielt legemsvaesker og et analytisk middel for bruk i en slik fremgangsmaate

Country Status (9)

Country	Link
US (2)	US4550085A (de)
EP (1)	EP0082862B1 (de)
JP (1)	JPS58501055A (de)
AU (1)	AU563306B2 (de)
DE (1)	DE3268798D1 (de)
DK (1)	DK157218C (de)
FI (1)	FI74818C (de)
NO (1)	NO830732L (de)
WO (1)	WO1983000229A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1226796A (en) *	1983-11-07	1987-09-15	Anand Kumar	Reflective particle-containing analytical element
CA1225574A (en) *	1983-11-07	1987-08-18	Anand Kumar	Reflective particle-containing solvent extraction reagent composition
US5098831A (en) *	1988-08-11	1992-03-24	Allergifonden Af 1981	Method and means for allergy diagnosis
AU637769B2 (en) *	1988-08-11	1993-06-10	Allergifonden Af 1981	Method and means for allergy diagnosis
US5041390A (en) *	1988-08-11	1991-08-20	Skov Per S	Method and means for allergy diagnosis
US5468650A (en) *	1988-10-17	1995-11-21	A/S Lundbeck Export Division Ltd.	Class microfiber histamine assay device
US5279937A (en) *	1992-04-30	1994-01-18	Detechnology Canada	Use of macroglobulins to improve the signal-to-background ratio in affinity binding assays
AU5654099A (en) *	1998-09-25	2000-04-17	Kikkoman Corporation	Histamine dehydrogenase, process for producing the same, method for quantitatinghistamine and quantification reagent
US8420054B2 (en) *	2009-09-18	2013-04-16	The Procter & Gamble Company	Noninvasive method for measuring histamine from skin as an objective measurement of itch
WO2011056561A1 (en)	2009-10-27	2011-05-12	Beth Israel Deaconess Medical Center	Methods and compositions for the generation and use of conformation-specific antibodies
US10487114B2 (en)	2011-04-27	2019-11-26	Beth Israel Deaconess Medical Center, Inc.	Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
WO2014093819A2 (en)	2012-12-14	2014-06-19	The Procter & Gamble Company	Antiperspirant and deodorant compositions
US9176110B1 (en) *	2013-09-13	2015-11-03	The United States Of America, As Represented By The Secretary Of Agriculture	Method of determining histamine concentration in fish
RU2622003C1 (ru) *	2016-06-15	2017-06-08	Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России	Способ оценки гиперчувствительности по высвобождению гистамина из лейкоцитов цельной крови
EP4058810A4 (de) *	2019-11-15	2023-12-20	President And Fellows Of Harvard College	Vorrichtung und verfahren zur analytdetektion
CN112326578B (zh) *	2020-12-01	2024-04-12	云南省农业科学院农产品加工研究所	一种快速检测食品中组胺的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1242493A (en) *	1969-12-05	1971-08-11	Roy Laver Swank	Blood treating method and apparatus
IT1006557B (it) *	1971-09-08	1976-10-20	Bagshawe Kenneth Dawson	Cella di reazione particolarmente utile in prove di radioimmunita
US3941876A (en) *	1973-04-25	1976-03-02	Gte New Ventures Corporation	In vitro method for determining allergic hypersensitivity
US4014651A (en) *	1973-05-14	1977-03-29	Mallinckrodt, Inc.	Method for determining thyroid function and reagent composition therefor
US4020151A (en) *	1976-02-17	1977-04-26	International Diagnostic Technology, Inc.	Method for quantitation of antigens or antibodies on a solid surface
JPS587332Y2 (ja) *	1978-06-06	1983-02-08	富士写真フイルム株式会社	多層血液化学分析材料
US4235601A (en) *	1979-01-12	1980-11-25	Thyroid Diagnostics, Inc.	Test device and method for its use
US4297337A (en) *	1979-04-13	1981-10-27	Corning Glass Works	Solid-phase immunoassays using magnetic glass
US4299813A (en) *	1979-05-17	1981-11-10	Snyder Solomon H	Assay kit and method
US4249918A (en) *	1979-05-21	1981-02-10	Monsanto Company	Fiber bed element and process for removing aerosols from gases
US4331650A (en) *	1980-07-18	1982-05-25	Science Research Center, Inc.	Identification of reagins in the blood serum of allergen sensitized vertebrates
DE3029579C2 (de) *	1980-08-05	1985-12-12	Boehringer Mannheim Gmbh, 6800 Mannheim	Verfahren und Mittel zur Abtrennung von Plasma oder Serum aus Vollblut
US4629706A (en) *	1982-02-01	1986-12-16	Miles Laboratories, Inc.	Method for determining allergic sensitivity
US4579828A (en) *	1983-12-15	1986-04-01	Becton, Dickinson And Company	Clot activator for serum separation tubes

1981
- 1981-07-06 DK DK298281A patent/DK157218C/da not_active IP Right Cessation
- 1981-09-08 US US06/300,262 patent/US4550085A/en not_active Expired - Lifetime
1982
- 1982-07-06 DE DE8282902066T patent/DE3268798D1/de not_active Expired
- 1982-07-06 EP EP82902066A patent/EP0082862B1/de not_active Expired
- 1982-07-06 AU AU86859/82A patent/AU563306B2/en not_active Ceased
- 1982-07-06 WO PCT/DK1982/000064 patent/WO1983000229A1/en not_active Ceased
- 1982-07-06 JP JP57502112A patent/JPS58501055A/ja active Granted
1983
- 1983-03-03 NO NO830732A patent/NO830732L/no unknown
- 1983-03-04 FI FI830732A patent/FI74818C/fi not_active IP Right Cessation
1985
- 1985-10-28 US US06/791,722 patent/US4869875A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JPH0319948B2 (de)	1991-03-18
DK298281A (da)	1983-01-07
AU563306B2 (en)	1987-07-02
DK157218B (da)	1989-11-20
DK157218C (da)	1990-04-23
EP0082862A1 (de)	1983-07-06
FI74818B (fi)	1987-11-30
WO1983000229A1 (en)	1983-01-20
FI74818C (fi)	1988-03-10
EP0082862B1 (de)	1986-01-29
US4550085A (en)	1985-10-29
JPS58501055A (ja)	1983-06-30
DE3268798D1 (en)	1986-03-13
US4869875A (en)	1989-09-26
AU8685982A (en)	1983-02-02
FI830732A0 (fi)	1983-03-04
FI830732L (fi)	1983-03-04

Publication	Publication Date	Title
US5910421A (en)	1999-06-08	Rapid diagnostic method for distinguishing allergies and infections
NO830732L (no)	1983-03-03	Fremgangsmaate for detektering eller bestemmelse av histamin i histaminholdige materialer, spesielt legemsvaesker og et analytisk middel for bruk i en slik fremgangsmaate
US20020137117A1 (en)	2002-09-26	Rapid diagnostic method for distinguishing allergies and infections and nasal secretion collection unit
JP2676108B2 (ja)	1997-11-12	血液滴または任意の生物媒質に由来する液からの物質の免疫酵素的検出装置
DK174032B1 (da)	2002-04-29	Sæt samt fremgangsmåde til immunometrisk dosering, der kan anvendes på hele celler
JP3451091B2 (ja)	2003-09-29	全血試料中に存在する分析対象成分の定量に用いる分析用キュベット、定量方法及び診断検査キット
JP2990528B2 (ja)	1999-12-13	ガンおよび前ガン状態の検出のための直腸粘液テストおよびキット
US5827681A (en)	1998-10-27	Rapid detection and drug sensitivity of malaria
Ownby et al.	1984	Development and comparative evaluation of a multiple-antigen RAST as a screening test for inhalant allergy
US20060105402A1 (en)	2006-05-18	Blood type method system and device
JPH0630633B2 (ja)	1994-04-27	アレルギーの検出法並びに該方法に好適な試薬及び装置、及びアレルギー用薬及び抗炎症剤の測定法
US6461825B1 (en)	2002-10-08	Immunometric assay kit and method applicable to whole cells
Nalebuff	1992	In vitro testing methodologies: evolution and current status
US7270974B1 (en)	2007-09-18	Rapid diagnostic method for detecting bacterial sinusitis
Johansson	1978	In vitro diagnosis of reagin-mediated allergic diseases.
EP0428606B1 (de)	1994-10-19	Verfahren und mittel- zur diagnose für allergien
US3476514A (en)	1969-11-04	Cancer cytoscreening
CN120820725B (zh)	2026-01-27	胶质纤维酸性蛋白和乳酸脱氢酶a亚型在制备诊断颅脑创伤的试剂盒中的用途
Rieuwpassa et al.	2020	Non-invasive early diagnosis of oral squamous cell carcinoma using piezoelectric biosensor
Angel et al.	2026	Wave VI Neurodegeneration
Whitsel et al.	2022	Neurodegeneration
RU1803873C (ru)	1993-03-23	Способ диагностики аллергии
Immundiagnostik	2015	Lysozyme ELISA
JP2002250729A (ja)	2002-09-06	モノクローナル抗体組成物、血液型判定方法およびキット
Insert	0	SCREEN IFA TEST CK-MB